Ignite Creation Date:
2024-05-06 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05929807
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-16
First Post:
2023-06-06
Brief Title:
A Clinical Trial to Investigate Long-term Safety Tolerability and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
Sponsor:
Ascendis Pharma Growth Disorders AS
Organization:
Ascendis Pharma AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-21
Start Date Type:
ACTUAL
Primary Completion Date:
2039-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2039-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-06
First Submit QC Date:
June 30 2023
Study First Post Date:
2023-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-04
Last Update Post Date:
2024-04-16
Last Update Post Date Type:
ACTUAL